神經膠質纖維酸性蛋白(GFAP)檢測試劑盒(酶聯免疫吸附試驗法)
ELISA Kit for Glial Fibrillary Acidic Protein (GFAP)
Intermediate Filament Protein
- 編號SEA068Mu
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 實驗方法雙抗夾心
- 反應時長3h
- 檢測范圍15.6-1,000pg/mL
- 靈敏度最小可檢測劑量小于等于6.0pg/mL.
- 樣本類型serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- 下載 英文說明書 中文說明書
- 規格 48T96T 96T*5 96T*10 96T*100
- 價格 ¥ 2722 ¥ 3888 ¥ 17496 ¥ 33048 ¥ 272160
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
實驗結果圖
-
標準曲線圖
-
通過ISO 9001、ISO 13485質量體系認證
特異性
本試劑盒用于檢測神經膠質纖維酸性蛋白(GFAP)，經檢測與其它相似物質無明顯交叉反應。
由于受到技術及樣本來源的限制，不可能完成對所有相關或相似物質交叉反應檢測，因此本試劑盒有可能與未經檢測的其它物質有交叉反應。
回收率
分別于定值血清及血漿樣本中加入一定量的神經膠質纖維酸性蛋白(GFAP)（加標樣品），重復測定并計算其均值，回收率為測定值與理論值的比率。
| 樣本 | 回收率范圍(%) | 平均回收率(%) |
| serum(n=5) | 80-102 | 83 |
| EDTA plasma(n=5) | 87-96 | 92 |
| heparin plasma(n=5) | 85-98 | 88 |
精密度
精密度用樣品測定值的變異系數CV表示。CV(%) = SD/mean×100
批內差：取同批次試劑盒對低、中、高值定值樣本進行定量檢測,每份樣本連續測定20 次，分別計算不同濃度樣本的平均值及SD值。
批間差：選取3個不同批次的試劑盒分別對低、中、高值定值樣本進行定量測定，每個樣本使用同一試劑盒重復測定8次，分別計算不同濃度樣本的平均值及SD值。
批內差： CV<10%
批間差： CV<12%
線性
在定值血清及血漿樣本內加入適量的神經膠質纖維酸性蛋白(GFAP)，并倍比稀釋成1:2，1:4，1:8，1:16的待測樣本，線性范圍即為稀釋后樣本中神經膠質纖維酸性蛋白(GFAP)含量的測定值與理論值的比率。
| 樣本 | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 88-101% | 91-98% | 78-101% | 78-92% |
| EDTA plasma(n=5) | 88-101% | 94-102% | 78-94% | 92-105% |
| heparin plasma(n=5) | 99-105% | 88-105% | 96-105% | 96-104% |
穩定性
經測定，試劑盒在有效期內按推薦溫度保存，其活性降低率小于5%。
為減小外部因素對試劑盒破壞前后檢測值的影響，實驗室的環境條件需盡量保持一致，尤其是實驗室內溫度、濕度及溫育條件。其次由同一實驗員來進行操作可減少人為誤差。
實驗流程
1. 實驗前標準品、試劑及樣本的準備；
2. 加樣（標準品及樣本）100µL，37°C孵育1小時；
3. 吸棄，加檢測溶液A100µL，37°C孵育1小時；
4. 洗板3次；
5. 加檢測溶液B100µL，37°C孵育30分鐘；
6. 洗板5次；
7. 加TMB底物90µL，37°C孵育10-20分鐘；
8. 加終止液50µL，立即450nm讀數。
實驗原理
將神經膠質纖維酸性蛋白(GFAP)抗體包被于96孔微孔板中，制成固相載體，向微孔中分別加入標準品或標本，其中的神經膠質纖維酸性蛋白(GFAP)與連接于固相載體上的抗體結合，然后加入生物素化的神經膠質纖維酸性蛋白(GFAP)抗體，將未結合的生物素化抗體洗凈后，加入HRP標記的親和素，再次徹底洗滌后加入TMB底物顯色。TMB在過氧化物酶的催化下轉化成藍色，并在酸的作用下轉化成最終的黃色。顏色的深淺和樣品中的神經膠質纖維酸性蛋白(GFAP)呈正相關。用酶標儀在450nm波長下測定吸光度(O.D.值)，計算樣品濃度。
增值服務
相關產品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPA068Mu03 | 神經膠質纖維酸性蛋白(GFAP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA068Mu02 | 神經膠質纖維酸性蛋白(GFAP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA068Mu01 | 神經膠質纖維酸性蛋白(GFAP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA068Mu04 | 神經膠質纖維酸性蛋白(GFAP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA068Mu03 | 神經膠質纖維酸性蛋白(GFAP)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA068Mu02 | 神經膠質纖維酸性蛋白(GFAP)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA068Mu01 | 神經膠質纖維酸性蛋白(GFAP)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA068Mu04 | 神經膠質纖維酸性蛋白(GFAP)多克隆抗體 | WB; IHC; ICC; IP. |
| MAA068Mu22 | 神經膠質纖維酸性蛋白(GFAP)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA068Mu23 | 神經膠質纖維酸性蛋白(GFAP)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA068Mu21 | 神經膠質纖維酸性蛋白(GFAP)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA068Mu24 | 神經膠質纖維酸性蛋白(GFAP)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA068Mu25 | 神經膠質纖維酸性蛋白(GFAP)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA068Mu27 | 神經膠質纖維酸性蛋白(GFAP)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA068Mu28 | 神經膠質纖維酸性蛋白(GFAP)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA068Mu29 | 神經膠質纖維酸性蛋白(GFAP)單克隆抗體 | WB; IHC; ICC; IP. |
| SEA068Mu | 神經膠質纖維酸性蛋白(GFAP)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| MEA068Mu | 神經膠質纖維酸性蛋白(GFAP)檢測試劑盒(酶聯免疫吸附試驗法,小樣本) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA068Mu | 神經膠質纖維酸性蛋白(GFAP)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
| KSA068Mu01 | 神經膠質纖維酸性蛋白(GFAP)檢測試劑盒DIY材料(酶聯免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| Journal of Occupational Health | Effects of Exposure to 1-Bromopropane on Astrocytes and Oligodendrocytes in Rat Brain [Pubmed: 23183024] |
| Morfovirtual 2014 | EFECTO PROTECTOR DEL TRATAMIENTO CON NEUROEPO SOBRE LA GLIA DE LA CORTEZA CEREBRAL EN RATONES TRANSGéNICOS CON LA ENFERMEDAD DE ALZHEIMER. [Sld:Source] |
| Annals of Anatomy | Effect of memantine, a NMDA receptor blocker, on ethambutol-induced retinal injury [PubMed: 26704355] |
| Mediators of Inflammation | IL-4 Inhibits IL-1β-Induced Depressive-Like Behavior and Central Neurotransmitter Alterations [PubMed: 26417153] |
| Neurochem Res | Protective Effect of Oral Hesperetin Against Unilateral Striatal 6-Hydroxydopamine Damage in the Rat [PubMed: 26700436] |
| Cell Mol Neurobiol | Hypericum Perforatum Hydroalcoholic Extract Mitigates Motor Dysfunction and is Neuroprotective in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson’s Disease [PubMed: 26119304] |
| Sleep and Biological Rhythms | Relationship of orexin (hypocretin) system and astrocyte activation in Parkinson's disease with hypersomnolence [Doi: 10.1111] |
| Cellular and Molecular Neurobiology | Hypericum Perforatum?Hydroalcoholic Extract Mitigates Motor Dysfunction and is Neuroprotective in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson’s Disease [Pubmed:26119304] |
| Ann Anat | Effect of memantine: A NMDA receptor blocker, on ethambutol-induced retinal injury [Pubmed:26704355] |
| United States Patent Application | ESTROGENIC COMPONENTS FOR USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS [y2016:0101116.html] |
| Clinical Research | Human plasma glial fibrillary acidic protein and heat shock protein 27 concentrations in acute moderate-intensity aerobic exercise with different duration [a825e1e27b0221df9a627769c0f614432e92.pdf] |
| Medical Journal of Indonesia | Comparison of GFAP and HSP27 concentrations in acute moderate-intensity aerobic exercise of different duration [2031884] |
| Peptides. | Carnosine ameliorates cognitive deficits in streptozotocin-induced diabetic rats: Possible involved mechanisms. [pubmed:27777064] |
| european journal of pharmacology | Garlic active constituent s-allyl cysteine protects against lipopolysaccharide-induced cognitive deficits in the rat: Possible involved mechanisms. [pubmed:27915041] |
| european journal of pharmacology | Troxerutin exerts neuroprotection in 6-hydroxydopamine lesion rat model of Parkinson's disease: Possible involvement of PI3K/ERβ signaling. [pubmed:28284752] |
| biomedicine & pharmacotherapy | Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat. [pubmed:28199883] |
| J Endocrinol.? | Estrogen receptors and estetrol-dependent neuroprotective actions: a pilot study. [pubmed:27799463] |
| IOS Press Content Library | An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's … [articles:journal-of-alzheimers-disease] |
| Tier?rztliche Hochschule Hannover | Evaluierung von Biomarkern im Liquor cerebrospinalis bei paraplegischen Hunden mit Ru?ckenmarksverletzung [:] |
| Nigerian Journal of Clinical Practice | Utilization of Glial Fibrillary Acidic Protein and Galectin-3 in the Diagnosis of Cerebral Infarction Patients with Normal Cranial Tomography [pubmed:28406123] |
| Cytokine | Soy isoflavone genistein attenuates lipopolysaccharide-induced cognitive impairments in the rat via exerting anti-oxidative and anti-inflammatory effects [pubmed:29102164] |
| Biomedicine & pharmacotherapy | Berberine ameliorates intrahippocampal kainate-induced status epilepticus and consequent epileptogenic process in the rat: Underlying mechanisms [pubmed:28061403] |
| Experimental gerontology | The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling. [pubmed:29107062] |
| Pesticide Biochemistry and Physiology | Acrolein-mediated neurotoxicity in growing Wistar male rats [Pubmed:30033014] |
| Journal of Perinatal Medicine | Mechanisms of death in structurally normal stillbirths [Pubmed: 30231013] |
| Metabolic?Brain?Disease | Berberine ameliorates lipopolysaccharide-induced learning and memory deficit in the rat: insights into underlying molecular mechanisms [Pubmed: 30456649] |
| Metabolic?Brain?Disease | Trigonelline protects hippocampus against intracerebral Aβ (1–40) as a model of Alzheimer's disease in the rat: insights into underlying mechanisms [Pubmed: 30421246] |
| 博士論文 | INSTITUTO DE CIENCIAS BáSICAS Y PRECLíNICAS “VICTORIA DE GIRóN” DEPARTAMENTO DE HISTOLOGíA [] |
| Medicina | The Administration of the New Pyrimidine Derivative—4-{2-[2-(3, 4-Dimethoxyphenyl)-Vinyl]-6-Ethyl-4-Oxo-5-Phenyl-4H-Pyrimidine-1-Il} Benzsulfamide Restores the?… [] |
| Open Access Macedonian Journal of Medical Sciences | Inhibition of Receptor for Advanced Glycation End Products as New Promising Strategy Treatment in Diabetic Retinopathy [Pubmed: 32165929] |
| NEUROPSYCHOBIOLOGY | Diosgenin Attenuates Cognitive Impairment in Streptozotocin-Induced Diabetic Rats: Underlying Mechanisms [Pubmed: 32526752] |
| JAMA Surgery | Intraoperative dexmedetomidine for prevention of postoperative delirium in elderly patients with mild cognitive impairment [Pubmed: 28593326] |
| Acta Histochemica | Quercetin mitigates monosodium glutamate-induced excitotoxicity of the spinal cord motoneurons in aged rats via p38 MAPK inhibition [Pubmed: 32622428] |
| stanbul Med J | The Predictive Role of Neurobiochemical Markers in Multiple Sclerosis. [] |
| Basic and Clinical Neuroscience | Paeonol Protects Against Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson's Disease [33995926] |
| pharmacology online | PHARMACOLOGICAL SCREENING OF A POTENTIALLY EFFECTIVE COMPOUND FOR THE TREATMENT OF CHRONIC TRAUMATIC ENCEPHALOPATHY??- [] |
| Neuropeptides | The bee venom active compound melittin protects against bicuculline-induced seizures and hippocampal astrocyte activation in rats [34808488] |
| Neural Plast | P2Y2 Receptor Mediated Neuronal Regeneration and Angiogenesis to Affect Functional Recovery in Rats with Spinal Cord Injury [Pubmed:35154311] |
留言咨詢
